Status:
COMPLETED
Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Characterization and Prospective Course
Lead Sponsor:
University of Minnesota
Conditions:
PANS
PANDAS
Eligibility:
All Genders
4-16 years
Brief Summary
This study is a brief (3 month) longitudinal study following children between the ages of 4-16 years old who have been diagnosed with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). Parents an...
Eligibility Criteria
Inclusion
- English-speaking boys and girls ages 4-16 years
- Abrupt onset of OCD or severely restricted food intake
- At least 2 equally abrupt-onset concurrent neuropsychiatric symptoms from the following 7 categories: anxiety, emotional lability/depression, irritability/aggression/severely oppositional behaviors, behavioral/developmental regression, deterioration in school performance, sensory or motor abnormalities (e.g. tics), somatic symptoms (e.g., urinary, sleep)
- Neuropsychiatric symptoms are not better explained by a known neurological or medical disorder.
Exclusion
- \- Too unstable psychiatrically or medically to participate safely in the protocol, per clinical judgment of the Principal Investigator or Co-Investigator
Key Trial Info
Start Date :
May 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2019
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04382716
Start Date
May 2 2018
End Date
August 15 2019
Last Update
May 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55454